US Federal Prisons Must Provide Hormone Therapy to Transgender Inmates

A ruling mandates that U.S. federal prisons must provide cross-sex hormone therapy to transgender inmates. Approximately 628 federal prisoners currently receive this treatment. The decision aims to ensure access to necessary medical care for transgender individuals within the federal prison system. This ruling addresses healthcare rights for a vulnerable population. The report was published on June 17, 2026.

This ruling addresses the healthcare rights of transgender inmates, ensuring access to necessary medical treatment within the federal prison system.